25 Recruiting Metastatic Pancreatic Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Metastatic Pancreatic Cancer
Top Recruiting Metastatic Pancreatic Cancer Studies
🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
📍 University of California Davis — Sacramento, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
📍 Lombardi Comprehensive Cancer Center, Georgetown University — Washington D.C., District of Columbia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Saltikva for Metastatic Pancreatic Cancer
📍 Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial — Montreal, Quebec
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
📍 Zuckerberg Cancer Center — New Hyde Park, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
📍 Mary Crowley Cancer Research Center — Dallas, Texas
View Study & Checklist ➔